Imbalanced TREM2/CX3CR1 signaling drives microglial hyperactivation and impaired amyloid clearance. Loss of TREM2 activation combined with elevated CX3CL1-CX3CR1 signaling creates a pro-inflammatory microglial state resistant to transition to disease-associated microglia (DAM), preventing efficient phagocytosis of amyloid plaques while maintaining neurotoxic cytokine release.
Pericyte-to-fibroblast transition contributes to BBB breakdown and impairs glymphatic clearance. Chronic PDGFRβ signaling triggers pericytes to undergo partial endothelial-mesenchymal transition. These transition-state pericytes lose coverage but gain contractile apparatus, compressing capillaries and reducing cerebral blood flow while impairing AQP4 polarisation necessary for glymphatic clearance.
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
Unspecified MechanismVascularneurodegeneration
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
10/11
dimensions won
TREM2-CX3CR1 Axis Dysregulation in Micro
2/11
dimensions won
Blood-Brain Barrier Pericyte-to-Mesenchy
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.68
0.55
Evidence
0.78
0.62
Novelty
0.62
0.68
Feasibility
0.70
0.50
Impact
0.75
0.58
Druggability
0.72
0.48
Safety
0.55
0.52
Competition
0.80
0.50
Data
0.85
0.58
Reproducible
0.70
0.52
KG Connect
0.50
0.50
Score Breakdown
Dimension
TREM2-CX3CR1 Axis Dysregulatio
Blood-Brain Barrier Pericyte-t
Mechanistic
0.680
0.550
Evidence
0.780
0.620
Novelty
0.620
0.680
Feasibility
0.700
0.500
Impact
0.750
0.580
Druggability
0.720
0.480
Safety
0.550
0.520
Competition
0.800
0.500
Data
0.850
0.580
Reproducible
0.700
0.520
KG Connect
0.500
0.500
Evidence
TREM2-CX3CR1 Axis Dysregulation in Microglial Surveillance F